Patents by Inventor Rahul K. Nath

Rahul K. Nath has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chemotherapy involving antisense oligonucleotides for preventing and/or treating pulmonary fibrosis
    Patent number: 8173612
    Abstract: The invention provides, in the treatment of malignant tumors, antisense DNA oligonucleotides which are effective in inhibiting the expression of a wild type COL1A1 gene, in combination with a chemotherapy drug, typically bleomycin, cyclophosphamide, or methotrexate, which otherwise is known to cause lung disease such as pulmonary fibrosis.
    Type: Grant
    Filed: September 15, 2006
    Date of Patent: May 8, 2012
    Inventors: Rahul K. Nath, Usha Nath
  • Chemotherapy involving antisense oligonucleotides for preventing and/or treating pulmonary fibrosis
    Publication number: 20110172162
    Abstract: The invention provides, in the treatment of malignant tumors, antisense DNA oligonucleotides which are effective in inhibiting the expression of a wild type COL1A1 gene, in combination with a chemotherapy drug, typically bleomycin, cyclophosphamide, or methotrexate, which otherwise is known to cause lung disease such as pulmonary fibrosis.
    Type: Application
    Filed: September 15, 2006
    Publication date: July 14, 2011
    Inventors: Rahul K. Nath, Usha Nath
  • Therapy inhalation involving antisense oligonucleotides for treating idiopathic pulmonary fibrosis
    Patent number: 7396823
    Abstract: The invention provides antisense DNA oligonucleotides which are effective in inhibiting the expression of a wild type COL1A1 gene, wherein said oligonucleotides are used in inhalation therapy to treat various lung diseases.
    Type: Grant
    Filed: December 21, 2004
    Date of Patent: July 8, 2008
    Inventors: Rahul K. Nath, Rajinder Beri